Georgios Antonios Margonis

Papers

Total Citations

H-Index

About

Dr. Georgios Antonios Margonis is a leading surgical oncologist and researcher whose work centers on precision medicine in colorectal cancer liver metastases, minimally invasive hepatobiliary surgery, and the molecular determinants of surgical outcomes. His major contributions include pioneering the concept of *genomically guided surgical decision-making*, demonstrating that specific genetic mutations—such as *RAS* and *BRAF*—profoundly influence recurrence patterns and survival after liver resection, thereby challenging one-size-fits-all surgical strategies. With over 4,000 citations, his landmark studies have reshaped international guidelines for the management of colorectal liver metastases. Notably, Dr. Margonis has also advanced the field of single-port and robotic hepatobiliary surgery, authoring seminal reviews on robotic single-port cholecystectomy that highlight the potential for reduced postoperative pain and improved cosmesis. His work has earned him multiple research awards, including the prestigious Americas Hepato-Pancreato-Biliary Association (AHPBA) Scientific Award. For students and researchers, Dr. Margonis exemplifies how integrating molecular biology with clinical surgery can transform patient care, making him a pivotal figure in the era of personalized surgical oncology.